Skip to main content

Chemotherapie und andere adjuvante Maßnahmen nach kurativer Intervention beim Kolonkarzinom

  • Chapter
  • First Online:
Chirurgie des Kolonkarzinoms

Zusammenfassung

Die adjuvante Chemotherapie ist ein wichtiger Bestandteil des Therapiekonzeptes beim Kolonkarzinom im Stadium UICC III und bei Patienten mit hohem Rezidivrisiko im Stadium UICC II. Obwohl in Deutschland unstrittig bleibt das perioperative Management insbesondere hinsichtlich interdisziplinärer Kommunikation, Vermeidung von Komplikationen und dem Ziel möglichst innerhalb von 8 Wochen die adjuvante systemische Behandlung einzuleiten eine Herausforderung. Das Kapitel adressiert weitere adjuvante Maßnahmen, die über eine klassische Chemotherapie hinausgehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • André T, Gramont A, Vernerey D et al (2015) Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in stage II to III Colon Cancer: updated 10-Year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol 33(35):4176–4187

    Google Scholar 

  • Fadelu T, Zhang S, Niedzwiecki D et al (2018) Nut consumption and survival in patients with stage III colon cancer: results from CALGB 89803 (Alliance). J Clin Oncol 36(11):1112–1120. https://doi.org/10.1200/JCO.2017.75.5413 (Epub 2018 Feb 28)

  • Grothey A, Sobrero AF, Shields AF et al (2018) Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med 378(13):1177–1188. https://doi.org/10.1056/NEJMoa1713709

  • Guinney J, Dienstmann R, Wang X et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350–1356

    Google Scholar 

  • Niedzwiecki D, Bertagnolli MM, Warren RS, Compton CC, Kemeny NE et al (2011) Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. J Clin Oncol 29(23):3146–3152

    Google Scholar 

  • Phipps AI, Shi Q, Newcomb PA, Nelson GD et al (2013) Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. J Clin Oncol 31(16):2016–2023. https://doi.org/10.1200/JCO.2012.46.2457 (Epub 2013 Apr 1)

  • Romiti A, Rulli E, Pilozzi E et al (2017) Exploring the prognostic role alysis of adjuvant chemotherapy for stage II colon cancer of microsatellite instability in patients with stage II colorectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer 16(2):e55–e59. https://doi.org/10.1016/j.clcc.2016.08.007 (Epub 2016 Aug 31)

  • Schmiegel W, Buchberger B, Follmann M et al (2017) S3-Leitlinie – kolorektales Karzinom. Z Gastroenterol 55(12):1344–1498. https://doi.org/10.1055/s-0043-121106. Epub 2017 Dec 6. inkl. Amendment Version 2.1 Januar 2019

  • Schmoll HJ, Tabernero J, Maroun J et al (2015) Capecitabine plus oxaliplatin compared with Fluorouracil/Folinic Acid as adjuvant therapy for stage III Colon Cancer: final results of the NO16968 randomized controlled phase III trial. J Clin Oncol. 33(32):3733–3740. https://doi.org/10.1200/JCO.2015.60.9107

  • Tie J, et al (2016) Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med 8(346):346ra92

    Google Scholar 

  • Twelves C, Wong A, Nowacki M et al (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352:2696–2704

    Google Scholar 

  • Van Blarigan EL, Meyerhardt JA (2015) Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol 33(16):1825–1834. https://doi.org/10.1200/JCO.2014.59.7799 (Epub 2015 Apr 27)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anke Reinacher-Schick .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nöpel-Dünnebacke, S., Reinacher-Schick, A. (2021). Chemotherapie und andere adjuvante Maßnahmen nach kurativer Intervention beim Kolonkarzinom. In: Benz, S., Grützmann, R., Stinner, B. (eds) Chirurgie des Kolonkarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60453-3_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-60453-3_30

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-60452-6

  • Online ISBN: 978-3-662-60453-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics